These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 13711411)

  • 41. The mechanism of resistance to sulfonamides; a quantitative study of the alternate metabolic pathways involving tryptophan and glucose metabolism, and aerobic and anaerobic growth conditions in relation to the mechanism of resistance.
    SEVAG MG; STEERS E
    Arch Biochem; 1949 Nov; 24(1):144-56. PubMed ID: 15400371
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacterial sulfonamide-sensitivity testing. A simple method for increasing in vitro reliability.
    COCCO AE; SMITH VM
    JAMA; 1961 Dec; 178():1106-8. PubMed ID: 13880069
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on tetracycline-resistant Escherichia coli strains requirement for 1-histidine.
    ENGLISH AR
    Proc Soc Exp Biol Med; 1960 Oct; 105():156-8. PubMed ID: 13696899
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of some antimicrobial preparations on the development of resistance to colimycin in colienteritis pathogens].
    KOVALENKO AD; CHERNOMORDIK AB
    Antibiotiki; 1961 Nov; 6():1021-5. PubMed ID: 14036903
    [No Abstract]   [Full Text] [Related]  

  • 45. [The significance of agar colloid in sulfonamide resistance tests].
    VORATZ H
    Arch Hyg Bakteriol; 1951; 135(2):150-7. PubMed ID: 14924593
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of the diuretic effect of a series of sulfonamides, in particular of 2-(4-chlorobenzene sulfonamido)-1,3,4-thiodiazole-sulfonamide (siccamid)].
    KUEHN G; GOERES E; JUNG F; HILGETAG G
    Acta Biol Med Ger; 1959; 3():574-87. PubMed ID: 14412496
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative bacteriological investigations on azo-sulfonamide salts and sulfonamides].
    NABERT-BOCK G
    Arzneimittelforschung; 1960 Feb; 10():125-7. PubMed ID: 14425676
    [No Abstract]   [Full Text] [Related]  

  • 48. Some aspects of the action of sulfonamides; rate-controlling processes in growth studies with Escherichia coli.
    MELCHIOR JB; KLOTZ IM
    Arch Biochem; 1949 Mar; 21(1):40-50. PubMed ID: 18113487
    [No Abstract]   [Full Text] [Related]  

  • 49. Sulphonamide-induced 'thymineless death' in Escherichia coli.
    Then R; Angehrn P
    J Gen Microbiol; 1973 Jun; 76(2):255-63. PubMed ID: 4579126
    [No Abstract]   [Full Text] [Related]  

  • 50. [A case of human glanders treated by sulfonamides: development of resistance of the glanders bacillus to sulfonamides during the treatment].
    EGHBAL M; RAFYI A; CHAMSY HM; FARVAR B
    Presse Med (1893); 1953 Nov; 61(75):1535-6. PubMed ID: 13134018
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug-resistance of enteric bacteria. 12. Transduction of the transmissible drug resistance factor by bacteriophage Plkc.
    KONDO E; HARADA K; MITSUHASHI S
    Jpn J Exp Med; 1962 Feb; 32():139-47. PubMed ID: 14458158
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bacteriological studies on sulfonamide preparations possessing intestinal activity].
    FREYTAG B
    Arzneimittelforschung; 1960 Mar; 10():165-70. PubMed ID: 13824963
    [No Abstract]   [Full Text] [Related]  

  • 53. [Linear growth of E. coli subjected to the action of p-aminobenzenesulfonamide].
    LAMENSANS A; FARI L
    C R Hebd Seances Acad Sci; 1960 Jan; 250():226-8. PubMed ID: 14413656
    [No Abstract]   [Full Text] [Related]  

  • 54. METHODS FOR MEASURING INHIBITION BY SULFONAMIDES OF THE ENZYMATIC SYNTHESIS OF DIHYDROPTEROIC ACID.
    BROWN GM
    Methods Med Res; 1964; 10():233-8. PubMed ID: 14284926
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic basis for sulfonamide resistance in Bacillus anthracis.
    Valderas MW; Bourne PC; Barrow WW
    Microb Drug Resist; 2007; 13(1):11-20. PubMed ID: 17536929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The problem of bacterial resistance to sulfonamides and penicillin].
    HAMEL J
    Med Klin; 1955 Jan; 50(1):24-6. PubMed ID: 14355552
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic experiences with a new sulfonamide mixture, dosulfin].
    CRAMER L
    Arztl Wochensch; 1956 Mar; 11(13):289-92. PubMed ID: 13326750
    [No Abstract]   [Full Text] [Related]  

  • 58. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
    Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
    J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations to sulfonamide resistance in Staphylococcus.
    OAKBERG E; LURIA SE
    J Bacteriol; 1946 Jul; 52():152. PubMed ID: 21065049
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the ribosome fraction of E. coli after chloramphenicol application].
    COUTELLE R; LINDIGKEIT R
    Acta Biol Med Ger; 1961; 6():178-85. PubMed ID: 13696043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.